Trials / Completed
CompletedNCT00190931
A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder
A Double-Blind Study of Functional Outcomes With Atomoxetine-Hydrochloride and Placebo in Adult Outpatients With DSM-IV Attention-Deficit/Hyperactivity Disorder
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 400 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
The overall primary objective of this study is to test the hypothesis that, compared with placebo,administration of atomoxetine will result in an improved work productivity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atomoxetine Hydrochloride | |
| DRUG | placebo |
Timeline
- Start date
- 2003-11-01
- Completion
- 2005-07-01
- First posted
- 2005-09-19
- Last updated
- 2006-07-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00190931. Inclusion in this directory is not an endorsement.